
Surmodics Inc
NASDAQ:SRDX

Surmodics Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
25.39
42.24
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Surmodics Inc hold over its rivals?
What risks and challenges
does Surmodics Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Surmodics Inc.
Provide an overview of the primary business activities
of Surmodics Inc.
What unique competitive advantages
does Surmodics Inc hold over its rivals?
What risks and challenges
does Surmodics Inc face in the near future?
Has there been any significant insider trading activity
in Surmodics Inc recently?
Summarize the latest earnings call
of Surmodics Inc.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Surmodics Inc.
Provide P/S
for Surmodics Inc.
Provide P/E
for Surmodics Inc.
Provide P/OCF
for Surmodics Inc.
Provide P/FCFE
for Surmodics Inc.
Provide P/B
for Surmodics Inc.
Provide EV/S
for Surmodics Inc.
Provide EV/GP
for Surmodics Inc.
Provide EV/EBITDA
for Surmodics Inc.
Provide EV/EBIT
for Surmodics Inc.
Provide EV/OCF
for Surmodics Inc.
Provide EV/FCFF
for Surmodics Inc.
Provide EV/IC
for Surmodics Inc.
Show me price targets
for Surmodics Inc made by professional analysts.
What are the Revenue projections
for Surmodics Inc?
How accurate were the past Revenue estimates
for Surmodics Inc?
What are the Net Income projections
for Surmodics Inc?
How accurate were the past Net Income estimates
for Surmodics Inc?
What are the EPS projections
for Surmodics Inc?
How accurate were the past EPS estimates
for Surmodics Inc?
What are the EBIT projections
for Surmodics Inc?
How accurate were the past EBIT estimates
for Surmodics Inc?
Compare the revenue forecasts
for Surmodics Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Surmodics Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Surmodics Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Surmodics Inc compared to its peers.
Compare the P/E ratios
of Surmodics Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Surmodics Inc with its peers.
Analyze the financial leverage
of Surmodics Inc compared to its main competitors.
Show all profitability ratios
for Surmodics Inc.
Provide ROE
for Surmodics Inc.
Provide ROA
for Surmodics Inc.
Provide ROIC
for Surmodics Inc.
Provide ROCE
for Surmodics Inc.
Provide Gross Margin
for Surmodics Inc.
Provide Operating Margin
for Surmodics Inc.
Provide Net Margin
for Surmodics Inc.
Provide FCF Margin
for Surmodics Inc.
Show all solvency ratios
for Surmodics Inc.
Provide D/E Ratio
for Surmodics Inc.
Provide D/A Ratio
for Surmodics Inc.
Provide Interest Coverage Ratio
for Surmodics Inc.
Provide Altman Z-Score Ratio
for Surmodics Inc.
Provide Quick Ratio
for Surmodics Inc.
Provide Current Ratio
for Surmodics Inc.
Provide Cash Ratio
for Surmodics Inc.
What is the historical Revenue growth
over the last 5 years for Surmodics Inc?
What is the historical Net Income growth
over the last 5 years for Surmodics Inc?
What is the current Free Cash Flow
of Surmodics Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Surmodics Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Surmodics Inc
NASDAQ:SRDX
|
441.5m USD | 150 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
227.6B USD | 22.7 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
177.9B USD | 59.4 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
145.4B USD | 35.9 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
141.7B USD | 24.5 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
113B USD | 14.1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
65.3B USD | 15.6 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
55.6B EUR | 16.1 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
42.2B USD | 23.8 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
278.7B CNY | 19.6 |
|
US |
![]() |
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
36.2B USD | 12.7 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Surmodics Inc
NASDAQ:SRDX
|
Average EV/EBITDA:
35.9
150
|
N/A | N/A | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
22.7
|
12%
|
1.9 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
59.4
|
25%
|
2.4 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
35.9
|
20%
|
1.8 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
24.5
|
12%
|
2 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
14.1
|
9%
|
1.6 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
15.6
|
12%
|
1.3 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
16.1
|
15%
|
1.1 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
23.8
|
11%
|
2.2 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
19.6
|
18%
|
1.1 |
|
US |
![]() |
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
12.7
|
12%
|
1.1 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.